ImmunologybioRxivPreprint
Assessments of hepatitis B virus-like particles and Crm197 as carrier proteins in melioidosis glycoconjugate vaccines
M. Bayliss, G. Pergolizzi, M. I. Donaldson…·J. L. Prior
This study compares the effectiveness of Crm197 and hepatitis B virus-like particles as carrier proteins for a melioidosis glycoconjugate vaccine, finding that Crm197 conjugates produce higher antibody titres but both protect against bacterial challenge.
DOI 10.1101/2020.04.08.031658